Central nervous system-adipose tissue axis in the pathogenesis of alcoholic liver disease
酒精性肝病发病机制中的中枢神经系统-脂肪组织轴
基本信息
- 批准号:10240705
- 负责人:
- 金额:$ 35.98万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2018
- 资助国家:美国
- 起止时间:2018-09-20 至 2023-08-31
- 项目状态:已结题
- 来源:
- 关键词:Adenovirus VectorAdipocytesAdipose tissueAdrenergic ReceptorAdverse effectsAffectAgonistAlcohol consumptionAlcoholic Liver DiseasesAlcoholsAnimal ModelAttenuatedBrown FatCannulasCell Culture TechniquesCell LineChemicalsChronicCirrhosisClinicalCoupledCouplingCyclic AMPCyclic AMP-Dependent Protein KinasesDataDenervationDevelopmentDietDiseaseDissociationDoseEnsureEthanolEventFatty AcidsFatty LiverFatty acid glycerol estersFibrosisFunctional disorderGene SilencingGeneticHealthHumanHypothalamic structureImpairmentIndividualInterventionInvestigationKnockout MiceLaboratoriesLipolysisLiverLiver FailureMammalsModelingMorbidity - disease rateMusNeuraxisNorepinephrineOperative Surgical ProceduresPathogenesisPathologicPathologyPathway interactionsPatientsPharmacologyPhenotypePhysiologicalPhysiologyPlayProcessReportingRoleSchemeSteatohepatitisSympathetic Nervous SystemTestingThermogenesisUnited Statesalcohol effectalcohol exposurealcohol responsealdehyde dehydrogenasesanalogbasechronic alcohol ingestionfeedingimplantationliver injurymortalityosmotic minipumpresponsetherapeutic target
项目摘要
Abstract
Alcoholic liver disease (ALD) remains an important health problem in the United States. It ranks among
the major causes of morbidity and mortality in the world, and affects millions of patients worldwide each
year. The disease process is characterized by early steatosis, steatohepatitis, with some individuals
ultimately progressing to fibrosis/cirrhosis and liver failure. Currently, there is no accepted therapy
available to halt or reverse this process in humans. Adipose tissue dysfunction plays a critical role in the
pathogenesis of ALD; however, the exact mechanisms underlying the detrimental effect of alcohol on
adipocyte function remain elusive. In mammals, adipose tissues comprise white adipose tissue (WAT)
and brown adipose tissue (BAT), which is further categorized into “classical” BAT and “inducible” beige
fat. The adipocytes in beige fat are Ucp1-expressing thermogenic adipocytes and can be induced to
manifest the phenotypes of classical brown adipocytes via a process called “browning”. Sympathetic
nervous system (SNS) is the primary initiator of both lipolysis and browning process through releasing
norepinephrine (NE) at target adipose tissues. Physiologically, a tightly-regulated “coupling” between
lipolytic and thermogenic machinery activation must be maintained to assure that most fatty acids
released from adipose tissue by lipolysis can be ultimately utilized for thermogenesis process/heat
production. The promotive effect of chronic alcohol consumption on lipolysis activation has been well-
documented, in contrast, its effect on adipose tissue browning/thermogenic process, as well as its
potential involvement in the pathogenesis of ALD development, remain unknown. Furthermore, although
the profound effect of alcohol on central nervous system (CNS) has been widely reported, whether and
how CNS contributes to these processes remain ambiguous. The data obtained recently in my laboratory
revealed that ALD development was associated with adipose tissue cAMP/PKA pathway activation.
Nevertheless, chronic alcohol exposure inhibited adipose tissue “browning”, implying a “dissociation”
between the two physiologically coupled processes in response to increased SNS tone in response to
alcohol drinking. Based on our Preliminary Studies, we hypothesize that chronic alcohol consumption
activates SNS, however, it “dissociates” the coupling between lipolysis and browning/thermogenesis in
adipose tissues, leading to uncontrolled FFAs release and resultant fatty liver and liver damage. This
hypothesis will be tested in the following Specific Aims: AIM 1: To determine the critical role of SNS
activation in adipose tissue lipolysis and liver pathologies in response to chronic alcohol exposure; AIM
2: To determine the pathological role of impaired browning/thermogenesis process in ALD and
mechanism(s) underlying alcohol-triggered uncoupling between lipolysis and browning/thermogenesis;
and AIM 3: To elucidate the mechanism(s) underlying alcohol-induced sympathetic activation.
摘要
酒精性肝病(ALD)在美国仍然是一个重要的健康问题。跻身
是世界上发病率和死亡率的主要原因,每年影响全球数百万患者,
年疾病过程的特点是早期脂肪变性,脂肪性肝炎,有些人
最终发展为纤维化/肝硬化和肝功能衰竭。目前,没有公认的治疗方法
可以阻止或逆转人类的这一过程。脂肪组织功能障碍在这一过程中起着关键作用。
ALD的发病机制;然而,酒精对ALD的有害影响的确切机制是,
脂肪细胞功能仍然是难以捉摸的。在哺乳动物中,脂肪组织包括白色脂肪组织(WAT)。
和棕色脂肪组织(BAT),其进一步分为“经典”BAT和“诱导型”米色
胖了米色脂肪中的脂肪细胞是表达Ucp 1的产热脂肪细胞,可以被诱导为
通过称为“布朗宁”的过程显示经典棕色脂肪细胞的表型。交感
神经系统(SNS)是脂肪分解和布朗宁过程的主要启动者,
去甲肾上腺素(NE)在目标脂肪组织。从生理学上讲,
必须保持脂解和产热机制的激活,以确保大多数脂肪酸
通过脂解从脂肪组织中释放的脂肪酸最终可用于产热过程/加热
生产长期饮酒对脂解激活的促进作用已经很好-
相反,记录了其对脂肪组织布朗宁/产热过程的影响,以及其
可能参与ALD发展的发病机制,仍然未知。此外,虽然
酒精对中枢神经系统(CNS)的深远影响已被广泛报道,无论
中枢神经系统如何促进这些过程仍不明确。最近在我的实验室获得的数据
显示ALD的发生与脂肪组织cAMP/PKA通路的激活有关。
然而,长期酒精暴露抑制脂肪组织“布朗宁”,这意味着“解离”
在两个生理上耦合的过程之间,响应于增加的SNS音调,
饮酒。根据我们的初步研究,我们假设长期饮酒
激活SNS,然而,它“解离”脂肪分解和布朗宁/产热之间的耦合,
脂肪组织,导致不受控制的FFA释放和由此产生的脂肪肝和肝损伤。这
将在以下具体目标中检验假设:目标1:确定SNS的关键作用
慢性酒精暴露引起的脂肪组织脂解和肝脏病理的激活
2:确定ALD中受损的布朗宁/产热过程的病理作用,
脂肪分解和布朗宁/产热之间的酒精触发解偶联的潜在机制;
目的3:阐明酒精诱导交感神经兴奋的机制。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
ZHENYUAN SONG其他文献
ZHENYUAN SONG的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('ZHENYUAN SONG', 18)}}的其他基金
Hepatic Nicotinamide N-Methyltransferase (NNMT) as a Pathogenetic Mechanism and Therapeutic Target for Alcoholic Liver Disease
肝脏烟酰胺 N-甲基转移酶 (NNMT) 作为酒精性肝病的发病机制和治疗靶点
- 批准号:
10684227 - 财政年份:2022
- 资助金额:
$ 35.98万 - 项目类别:
Homocysteine, Adiponectin, and Alcoholic Liver Disease
同型半胱氨酸、脂联素和酒精性肝病
- 批准号:
7905865 - 财政年份:2009
- 资助金额:
$ 35.98万 - 项目类别:
Homocysteine, Adiponectin, and Alcoholic Liver Disease
同型半胱氨酸、脂联素和酒精性肝病
- 批准号:
8121662 - 财政年份:2009
- 资助金额:
$ 35.98万 - 项目类别:
Homocysteine, Adiponectin, and Alcoholic Liver Disease
同型半胱氨酸、脂联素和酒精性肝病
- 批准号:
8516404 - 财政年份:2009
- 资助金额:
$ 35.98万 - 项目类别:
Homocysteine, Adiponectin, and Alcoholic Liver Disease
同型半胱氨酸、脂联素和酒精性肝病
- 批准号:
7663636 - 财政年份:2009
- 资助金额:
$ 35.98万 - 项目类别:
Homocysteine, Adiponectin, and Alcoholic Liver Disease
同型半胱氨酸、脂联素和酒精性肝病
- 批准号:
8311831 - 财政年份:2009
- 资助金额:
$ 35.98万 - 项目类别:
Mechanisms of Sensitization to TNF hepatotoxicity in ALD
ALD 中 TNF 肝毒性的致敏机制
- 批准号:
7279907 - 财政年份:2005
- 资助金额:
$ 35.98万 - 项目类别:
Mechanisms of Sensitization to TNF hepatotoxicity in ALD
ALD 中 TNF 肝毒性的致敏机制
- 批准号:
7800454 - 财政年份:2005
- 资助金额:
$ 35.98万 - 项目类别:
Mechanisms of Sensitization to TNF hepatotoxicity in ALD
ALD 中 TNF 肝毒性的致敏机制
- 批准号:
7123084 - 财政年份:2005
- 资助金额:
$ 35.98万 - 项目类别:
Mechanisms of Sensitization to TNF hepatotoxicity in ALD
ALD 中 TNF 肝毒性的致敏机制
- 批准号:
7485141 - 财政年份:2005
- 资助金额:
$ 35.98万 - 项目类别:
相似国自然基金
支链氨基酸代谢紊乱调控“Adipocytes - Macrophages Crosstalk”诱发2型糖尿病脂肪组织功能和结构障碍的作用及机制
- 批准号:81970721
- 批准年份:2019
- 资助金额:55.0 万元
- 项目类别:面上项目
相似海外基金
Recruitment of brown adipocytes in visceral white adipose tissue by fibroblast growth factor 8b
成纤维细胞生长因子 8b 将棕色脂肪细胞募集到内脏白色脂肪组织中
- 批准号:
321208980 - 财政年份:2016
- 资助金额:
$ 35.98万 - 项目类别:
Research Grants
Enhancing Energy Expending Adipocytes in White Adipose Tissue
增强白色脂肪组织中的能量消耗脂肪细胞
- 批准号:
8827438 - 财政年份:2014
- 资助金额:
$ 35.98万 - 项目类别:
Induction of brown-like adipocytes in white adipose tissue by food-derived factors
食物源性因子在白色脂肪组织中诱导棕色样脂肪细胞
- 批准号:
26450168 - 财政年份:2014
- 资助金额:
$ 35.98万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
WAT-on-a-chip - Development of a micofluidic, microphysiologic in vitro adipose tissue model for high-throughput drug screening based on hiPSC-derived adipocytes.
WAT-on-a-chip - 开发微流体、微生理体外脂肪组织模型,用于基于 hiPSC 衍生脂肪细胞的高通量药物筛选。
- 批准号:
257256526 - 财政年份:2014
- 资助金额:
$ 35.98万 - 项目类别:
Research Fellowships
Enhancing Energy Expending Adipocytes in White Adipose Tissue
增强白色脂肪组织中的能量消耗脂肪细胞
- 批准号:
8828181 - 财政年份:2013
- 资助金额:
$ 35.98万 - 项目类别:
Enhancing Energy Expending Adipocytes in White Adipose Tissue
增强白色脂肪组织中的能量消耗脂肪细胞
- 批准号:
8520690 - 财政年份:2013
- 资助金额:
$ 35.98万 - 项目类别:
Enhancing Energy Expending Adipocytes in White Adipose Tissue
增强白色脂肪组织中的能量消耗脂肪细胞
- 批准号:
8629741 - 财政年份:2013
- 资助金额:
$ 35.98万 - 项目类别:
Effect of exercise training on formation of brite adipocytes within white adipose tissue
运动训练对白色脂肪组织内脂肪细胞形成的影响
- 批准号:
23700778 - 财政年份:2011
- 资助金额:
$ 35.98万 - 项目类别:
Grant-in-Aid for Young Scientists (B)
Investigation for the mechanisms of the emergence of brown adipocytes in white adipose tissue
白色脂肪组织中棕色脂肪细胞出现机制的研究
- 批准号:
21780261 - 财政年份:2009
- 资助金额:
$ 35.98万 - 项目类别:
Grant-in-Aid for Young Scientists (B)
LOUISIANA COBRE: P1: INDUCE THERMOGENIC BROWN ADIPOCYTES IN WHITE ADIPOSE TISSUE
路易斯安那 COBRE:P1:在白色脂肪组织中诱导产热棕色脂肪细胞
- 批准号:
7610781 - 财政年份:2007
- 资助金额:
$ 35.98万 - 项目类别: